Pierre A. MORGON, PharmD, LL.M, MBA - CEO - Board Chair - INED - Mentor - Advisor

Dr Pierre A. Morgon has extensive work experience in the pharmaceutical and biotechnology industries. Currently, they serve as the Executive Vice President Portfolio Strategy & Supranational Affairs and Managing Director Europe at CanSino Biologics Inc. Dr Pierre A. is also an Independent Non-Executive Director at Limula and Chairman of the Board at Kupando GmbH, Amoéba, MYCB1 Group B.V., and Health Technology Holdings.

In addition, Dr Morgon holds the position of Independent Non-Executive Director and Executive Chairman of Quantoom Biosciences at UNIVERCELLS. Dr Pierre A. is also an Independent Non-Executive Director, Chair of the Governance Committee, and member of the Finance Committee at Vaccitech. Furthermore, they have served as an Expert, Mentor, and Judge at MassChallenge Switzerland.

Prior to their current roles, Dr Morgon was the Chief Executive Officer and Founder of MRGN Advisors, where they provided portfolio strategy, commercial and market access development, and investment advisory services to pharmaceutical, biologicals, vaccines, med tech, and healthcare IT companies. During this time, they advised Menarini, Eratech (a division of the Zambon group), Zambon, and Univercells on various strategic initiatives, including joint ventures, acquisitions, and partnerships.

Overall, Dr Pierre A. Morgon has a wealth of experience in strategic planning, business development, and advisory services within the healthcare industry.

Dr Pierre A. Morgon, PharmD, LL.M, MBA has a diverse education history. Dr Pierre A. obtained a Doctorate of Pharmacy, Magna cum Laude, from Université Claude Bernard Lyon 1 in 1985. Following this, they pursued a Master of Advances Studies in Business and Economic Law, cum Laude, from Université Jean Moulin (Lyon III) in 1986. Dr Morgon then continued their education at ESSEC Business School, where they obtained a Master in Marketing Management in 1988. In 1993, they attended INSEAD and completed the Young Managers Program, focusing on Business Administration and Management. Later, in 2001, they attended IMD for the Breakthrough Program for Senior Executives to further their knowledge in Business Administration and Management. Finally, in 2003, they attended INSEAD again, this time completing the Senior Executive Program CEDEP in Business Administration and Management.